Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Vet Ophthalmol ; 27(3): 286-289, 2024 May.
Article in English | MEDLINE | ID: mdl-38409733

ABSTRACT

A novel, simple, and inexpensive model for teaching depth of lesions within the cornea using slit lamp biomicroscopy to veterinary students, ophthalmology residents, and general clinicians with access to a slit lamp biomicroscope is described. Using common laboratory items, this method can be created in any clinic and can be used to teach and quiz students through independent study with objective self-testing achieved.


Subject(s)
Corneal Diseases , Education, Veterinary , Slit Lamp Microscopy , Animals , Slit Lamp Microscopy/veterinary , Slit Lamp Microscopy/instrumentation , Education, Veterinary/methods , Corneal Diseases/veterinary , Corneal Diseases/diagnosis , Ophthalmology/education , Slit Lamp/veterinary , Humans , Cornea/pathology
2.
Am J Vet Res ; 68(2): 190-202, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17269886

ABSTRACT

OBJECTIVE: To characterize the effects of oral administration of a high dose of enrofloxacin to cats. ANIMALS: 24 (12 male and 12 female) young healthy cats. PROCEDURES: Cats were allocated on the basis of sex into 2 groups (4 males and 4 females/ group) from which 3 subgroups for 3 durations (3, 5, or 7 days) of enrofloxacin (50 mg/kg, PO, q 24 h) or control solution (1 mL of water, PO, q 24 h) administration that began on day -1 were created. Funduscopic examinations were performed daily. Electroretinography (ERG) was performed before and every 2 to 3 days after the start of oral administration. Four cats/study group were euthanized on days 3, 5, and 7, and eyes were collected for light and electron microscopic evaluations. RESULTS: Neurologic, funduscopic, and ERG abnormalities were evident only in cats administered enrofloxacin. Funduscopic changes (granular appearance or graying of the area centralis) were noticed on or before day 3 (after only 3 days of enrofloxacin administration), with subsequent similar changes along the visual streak. Vascular attenuation (between days 2 and 4) and generalized tapetal hyperreflectivity (between days 5 and 7) followed. Reduction in b-wave ERG amplitude preceded funduscopic changes. Morphologic changes in the photoreceptor layers correlated with duration of enrofloxacin administration, with generalized degenerative changes evident after 3 doses. CONCLUSIONS AND CLINICAL RELEVANCE: The study indicated that a high dose of enrofloxacin (50 mg/kg/d, PO) induced retinal and systemic changes. Enrofloxacin at 10 times the recommended dosage is acutely toxic to the outer retina of clinically normal cats.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/adverse effects , Cat Diseases/chemically induced , Eye Diseases/chemically induced , Fluoroquinolones/administration & dosage , Fluoroquinolones/adverse effects , Administration, Oral , Animals , Behavior, Animal/drug effects , Body Temperature/drug effects , Cats , Enrofloxacin , Female , Heart Rate/drug effects , Male , Respiration/drug effects , Retina/drug effects , Retina/ultrastructure
3.
Vet Clin North Am Small Anim Pract ; 34(3): 669-91, 2004 May.
Article in English | MEDLINE | ID: mdl-15110978

ABSTRACT

Many variables affect the outcome of keratomycosis and systemic fungal infections in animals. These include pathogenicity of the fungal organism(toxins, trophisms, and evasion of host response); previous treatment with topical or systemic corticosteroids, which can have a dramatic negative impact on host defense mechanisms: concurrent systemic illness or immunocompromise: severity/extent of infection; and degree of pain (ie,increased reflex tearing dilutes topical medication) [14]. Experimental work suggests that antibiotics may occasionally exacerbate fungal infections [142],and some researchers advocate that concurrent antibiotic therapy is contraindicated in horses with yeast infections and septate fungal infections unless bacterial infection is also suspected [14]. Nevertheless, given that normal conjunctival flora often include bacteria and fungi and because care of keratomycoses often includes mixed bacterial and fungal infections, the possible dynamics (natural influences and local competition) between ocular surface microorganisms merit further investigation. There are many unanswered questions regarding the accuracy of in vitro susceptibilities and corneal concentration capabilities for antifungal topical medications [14]. Inherent host resistance or other immune interactions between the patient and fungus are perhaps the most important determinants of the outcome but are currently difficult to measure or assess except by subjective clinical observation [14].


Subject(s)
Antifungal Agents/administration & dosage , Eye Infections, Fungal/veterinary , Administration, Topical , Animals , Animals, Domestic , Drug Resistance, Fungal , Eye Infections, Fungal/drug therapy , Ophthalmic Solutions/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...